1. American Cancer Society 2022, Key Statistics for Lung Cancer. https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html, 2022 (accessed 18 November 2022).
2. American Society of Cancer Oncology, Lung Cancer - Non-Small Cell: Statistics. https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics, 2022 (accessed 2 November 2022).
3. Routine molecular profiling of patients with advanced non-small-cell lung cancer: Results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016
4. S.J. Rodig, M. Mino-Kenudson, S. Dacic, B.Y. Yeap, A. Shaw, J.A. Barletta, H. Stubbs, K. Law, N. Lindeman, E. Mark, P.A. Janne, T. Lynch, B.E. Johnson, A.J. Iafrate, L.R. Chirieac, Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population, Clin. Cancer Res. 15 (2009). https://doi.org/10.1158/1078-0432.CCR-09-0802.
5. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Non-Small Cell Lung Cancer V2.2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed April 4, 2023. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.